Moving from compliance to conscience: Why we can and should improve on the ethics of clinical research

Archives of Internal Medicine

Volumn 161, Issue 7, 2001, Pages 925-928

  Kahn, J P ^a   Mastroianni, A C ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL RESEARCH; CONSCIENCE; HEALTH CARE POLICY; INFORMED CONSENT; MEDICAL ETHICS; MEDICAL PRACTICE; MEDICAL RESEARCH; NOTE; PRIORITY JOURNAL;

EID: 0035832039     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.161.7.925     Document Type: Note

References (35)

1. Ethics and clinical research
2. Stricter regulation proposed for US gene therapy trials
3. Principles for human gene therapy studies
4. New voluntary standards are proposed for experiments on people
5. Keeping research subjects out of harm's way
6. Updating protections for human subjects involved in research: Project on Informed Consent, Human Research Ethics Group
7. Challenges to human subject protections in US medical research
8. Fair conduct and fair reporting of clinical trials
9. The evolving story of justice in federal research policy
10. Informed decision making in outpatient practice: Time to get back to basics
11. Advancing the cause of informed consent: From disclosure to understanding
12. Informed consent: A study of patient reaction
13. Disclosure of information to patients in medical care
14. Patient's perception of the quality of informed consent for common medical procedures
15. Research proposal review project
16. Controversy: Alternatives and decisions in complying with the doctrine of informed consent
17. Disclosure and informed consent
18. Informed consent in the Childrens Cancer Group: Results of preliminary research
19. Subject interview study
20. Trust: The fragile foundation of contemporary biomedical research
21. The therapeutic misconception: Informed consent in psychiatric research
22. Perceptions of cancer patients and their physicians involved in phase I trials
23. Medical research to get more money from government
24. Ethical dilemmas in medical innovation and research: Distinguishing experimentation from practice
25. Clinical trials and physicians as double agents
26. United Health still limiting some access: Changes give doctors more control, but insurer will deny certain services
27. New Jersey insurers will pay for care in cancer clinical trials
28. The importance of expanding current training in the responsible conduct of research